Galecto

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galecto and other ETFs, options, and stocks.

About GLTO

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3, lysyl oxidase-like 2, and LOXL2. 

CEO
Hans Thalsgård Schambye
CEOHans Thalsgård Schambye
Employees
13
Employees13
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2011
Founded2011
Employees
13
Employees13

GLTO Key Statistics

Market cap
22.56M
Market cap22.56M
Price-Earnings ratio
-0.54
Price-Earnings ratio-0.54
Dividend yield
Dividend yield
Average volume
169.56K
Average volume169.56K
High today
$0.8199
High today$0.8199
Low today
$0.76
Low today$0.76
Open price
$0.7745
Open price$0.7745
Volume
129.26K
Volume129.26K
52 Week high
$3.70
52 Week high$3.70
52 Week low
$0.50
52 Week low$0.50
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.